**Code**
| **Source**
| **MOA** |

1 |
IRAC |
Acetylcholinesterase inhibitors |

1 |
FRAC |
Methyl benzimidazole carbamates |

10 |
FRAC |
N-phenyl carbamates |

10 |
IRAC |
Mite growth inhibitors |

11 |
IRAC |
Microbial disruptors of insect midgut membranes |

11 |
FRAC |
Quinone outside inhibitors (QoI) |

12 |
FRAC |
Phenylpyrroles |

12 |
IRAC |
Inhibitors of mitochondrial ATP synthase |

13 |
FRAC |
Azanaphthalenes |

13 |
IRAC |
Uncouplers of oxidative phosphorylation via disruption of the proton gradient |

14 |
FRAC |
Aromatic hydrocarbons and heteroaromatics |

14 |
IRAC |
Nicotinic acetylcholine receptor channel blockers |

15 |
IRAC |
Inhibitors of chitin biosynthesis, type 0 |

16 |
IRAC |
Inhibitors of chitin biosynthesis, type 1 |

16.1 |
FRAC |
Melanin biosynthesis inhibitors - reductase (MBI-R) |

16.2 |
FRAC |
Melanin biosynthesis inhibitors - dehydratase (MBI-D) |

17 |
FRAC |
Hydroxyanilides and amino-pyrazolinone - SBI Class III |

17 |
IRAC |
Moulting disruptor, dipteran |

18 |
IRAC |
Ecdysone receptor agonists |

18 |
FRAC |
Thiocarbamates - SBI Class IV |

19 |
IRAC |
Octopamine receptor agonists |

19 |
FRAC |
Polyoxins |

2 |
IRAC |
GABA-gated chloride channel blockers |

2 |
FRAC |
Dicarboximides |

20 |
FRAC |
Phenylureas |

20 |
IRAC |
Mitochondrial complex III electron transport inhibitors |

21 |
IRAC |
Mitochondrial complex I electron transport inhibitors |

21 |
FRAC |
Quinone inside inhibitors (QiI) |

22 |
IRAC |
Voltage-dependent sodium channel blockers |

22 |
FRAC |
Benzamides (toluamides) and thaizole carboxamide |

23 |
IRAC |
Inhibitors of acetyl CoA carboxylase |

23 |
FRAC |
Enopyranuronic acid antibiotic |

24 |
IRAC |
Mitochondrial complex IV electron transport inhibitors |

24 |
FRAC |
Hexopyranosyl antibiotic |

25 |
IRAC |
Mitochondrial complex II electron transport inhibitors |

25 |
FRAC |
Glucopyranosyl antibiotic |

26 |
FRAC |
Glucopyranosyl antibiotic (formerly) |

27 |
FRAC |
Cyanoacetamideoxime |

28 |
IRAC |
Ryanodine receptor modulators |

28 |
FRAC |
Carbamates |

29 |
FRAC |
Uncouplers of oxidative phosphorylation |

29 |
IRAC |
Chordotonal organ modulators - undefined target site |

3 |
FRAC |
Demethylation inhibitors |

3 |
IRAC |
Sodium channel modulators |

30 |
FRAC |
Organo tin Compounds |

31 |
FRAC |
Carboxylic acids |

32 |
FRAC |
Heteroaromatics |

33 |
FRAC |
Phosphonates |

34 |
FRAC |
Phthalamic acids |

35 |
FRAC |
Benzotriazines |

37 |
FRAC |
Pyridazinones |

38 |
FRAC |
Thiophenecarboxamides |

39 |
FRAC |
Pyrimidinamines |

4 |
FRAC |
Phenylamides |

4 |
IRAC |
Nicotinic acetylcholine receptor competitive modulators |

40 |
FRAC |
Carboxylic acid amides |

41 |
FRAC |
Tetracycline antibiotic |

42 |
FRAC |
Thiocarbamate |

43 |
FRAC |
Benzamides (pyridinylmethylbenzamides) |

44 |
FRAC |
Microbial |

45 |
FRAC |
Quinone outside inhibitor, stigmatellin binding type (QoSI, QxI) |

46 |
FRAC |
Cell membrane disruption (proposed) - plant extract |

5 |
IRAC |
Nicotinic acetylcholine receptor allosteric modulators |

5 |
FRAC |
Amines (morpholines) - SBI Class II |

6 |
IRAC |
Glutamate-gated chloride channel allosteric modulators |

6 |
FRAC |
Phosphorothiolates and dithiolanes |

7 |
FRAC |
Succinate dehydrogenase inhibitors |

7 |
IRAC |
Juvenile hormone mimics |

8 |
IRAC |
Misc non-specific (multi-site) inhibitors |

8 |
FRAC |
Hydroxy-(2-amino-)pyrimidines |

9 |
FRAC |
Anilinopyrimidines |

9 |
IRAC |
Chordotonal organ TRPV channel modultators |

A |
HRAC |
ACCase lipid synthesis inhibitors |

B |
HRAC |
ALS inhibitors |

C1 |
HRAC |
Photosystem II (site A) inhibitors (triazines and others) |

C2 |
HRAC |
Photosystem II (site A) inhibitors (ureas and amides) |

C3 |
HRAC |
Photosystem II (site B) inhibitors (nitriles and others) |

D |
HRAC |
PS1 electron diversion (bipyridyliums) |

E |
HRAC |
PPO inhibitors |

F1 |
HRAC |
PDS inhibitors |

F2 |
HRAC |
4-HPPD inhibitors |

F3 |
HRAC |
Carotenoid biosynthesis inhibitors - unknown target (triazoles, ureas, isoxazolidiones) |

F4 |
HRAC |
DOXP synthase inhibitor |

G |
HRAC |
EPSP synthase inhibitors (glycines) |

H |
HRAC |
Glutamine synthetase inhibitors |

I |
HRAC |
DHP inhibitors |

K1 |
HRAC |
Mitosis inhibitors - microtubule assembly inhibitors (dinitroanilines and others) |

K2 |
HRAC |
Mitosis inhibitors - microtubule organization inhibitors (carbamates and others) |

K3 |
HRAC |
Mitosis inhibitors - very long chain fatty acid inhibitors (chloracetamides and others) |

L |
HRAC |
Cellulose synthesis inhibitors |

M |
HRAC |
Uncouplers - membrane disruptors |

M1 |
FRAC |
Inorganic |

M12 |
FRAC |
Polypeptide (from plant extract) - multiple effects |

M2 |
FRAC |
Inorganic |

M3 |
FRAC |
Dithiocarbamates and relatives |

M4 |
FRAC |
Phthalimides |

M5 |
FRAC |
Chloronitriles (phthalonitriles) |

M6 |
FRAC |
Sulfamides |

M7 |
FRAC |
Bis-guanidines |

M8 |
FRAC |
Triazines |

M9 |
FRAC |
Quinones (anthraquinones) |

N |
HRAC |
Non-ACCase lipid synthesis inhibitors (thiocarbamates and others) |

NC |
FRAC |
Not classified |

O |
HRAC |
Synthetic auxins |

P |
HRAC |
Auxin transport inhibitors |

P1 |
FRAC |
Host plant defense induction - salicylic acid pathway (benzothiadiazole) |

P4 |
FRAC |
Host plant defense induction (natural compound) |

P5 |
FRAC |
Host plant defense induction (plant extract) |

U12 |
FRAC |
Guanidines |

U13 |
FRAC |
Thiazolidine |

U15 |
FRAC |
Piperidinyl-thiazole-isoxazolinones |

U5 |
FRAC |
Thiazole carboxamide (formerly) |

U6 |
FRAC |
Phenylacetamide |

U8 |
FRAC |
Aryl-phenylketone |

UN |
IRAC |
Compounds of unknown or uncertain MOA |

Z |
HRAC |
Organoarsenicals |

Z |
HRAC |
Pyrazoliums |

Z |
HRAC |
Unknown |

Z. |
HRAC |
Unknown (arylaminopropionic acids) |